Managing Bleeding Risk in Patients with ITP

EP: 1.Understanding Immune Thrombocytopenia: Pathophysiology, Classification, and Differentiation

EP: 2.Diagnostic and Patient Education Strategies in ITP

Now Viewing

EP: 3.Managing Bleeding Risk in Patients with ITP

EP: 4.Living with ITP: Impact of Fatigue and Other Symptoms on Patients’ Quality of Life

EP: 5.Tailoring Care in ITP Through a Health Equity Lens

EP: 6.Looking Ahead in ITP: Addressing Unmet Needs and Embracing Innovation

Bleeding risk assessment in ITP patients directly correlates with platelet count - the lower the number, the higher the potential for bleeding. The risk is highest when counts fall below 10,000, with counts between 10,000-20,000 considered a gray area. Patients with counts below 20,000 face significantly elevated risks of spontaneous bleeding in critical areas including the gastrointestinal tract and brain.

A thorough medication history is essential as certain medications impact platelet function, further increasing bleeding risk. These include over-the-counter options like aspirin, cold medicines containing aspirin, and nonsteroidal anti-inflammatory drugs (NSAIDs). Patient education should emphasize avoiding these medications when platelet counts are low.

Healthcare providers should conduct detailed medication reviews including over-the-counter products, frequency of use, and reasons for use. Identifying potential substitutes that won't affect platelet function is critical when managing patients with very low platelet counts to minimize bleeding complications.